MICU2 up-regulation enhances tumor aggressiveness and metabolic reprogramming during colorectal cancer development
PLOS Biology · 2024
DOI: 10.1371/journal.pbio.3002854 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Biology, 2024. Verfasst von Alison Robert und 14 weiteren Autor:innen. Beteiligte Einrichtung: UMR Inserm 1069 N2COx « Niche, Nutrition, Cancer et métabolisme Oxydatif », Tours University, Tours, France. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Calcium-Binding Proteins, Mitochondria, Mitochondrial Membrane Transport Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: French departmental committees of Ligue Contre le Cancer "Grand-Ouest", Université de Tours and Région Centre-Val de Loire APR-IA CAMITHERAPAL, Ligue Contre le Cancer.
Abstract (Originalsprache)
The mitochondrial Ca 2+ uniporter (MCU) plays crucial role in intramitochondrial Ca 2+ uptake, allowing Ca 2+ -dependent activation of oxidative metabolism. In recent decades, the role of MCU pore-forming proteins has been highlighted in cancer. However, the contribution of MCU-associated regulatory proteins mitochondrial calcium uptake 1 and 2 (MICU1 and MICU2) to pathophysiological conditions has been poorly investigated. Here, we describe the role of MICU2 in cell proliferation and invasion using in vitro and in vivo models of human colorectal cancer (CRC). Transcriptomic analysis demonstrated an increase in MICU2 expression and the MICU2/MICU1 ratio in advanced CRC and CRC-derived metastases. We report that expression of MICU2 is necessary for mitochondrial Ca 2+ uptake and quality of the mitochondrial network. Our data reveal the interplay between MICU2 and MICU1 in the metabolic flexibility between anaerobic glycolysis and OXPHOS. Overall, our study sheds light on the potential role of the MICUs in diseases associated with metabolic reprogramming.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- UMR Inserm 1069 N2COx « Niche, Nutrition, Cancer et métabolisme Oxydatif », Tours University, Tours, France.
- CNRS UMR 6015, Inserm U1083 MITOVASC, MitoLab team, Angers University, Angers, France.
- PHENOMIN-TAAM-CNRS UPS44, Orléans, France.
Förderung
- French departmental committees of Ligue Contre le Cancer "Grand-Ouest"
- Université de Tours and Région Centre-Val de Loire APR-IA CAMITHERAPAL
- Ligue Contre le Cancer
- Inserm
- Fondation ARC
- Labex MabImprove
- INCa
- Région Centre Val-de-Loire
Zitieren
APA
Robert, A., Crottès, D., Bourgeais, J., Gueguen, N., Chevrollier, A., Dumas, J. F., Servais, S., Domingo, I., Chadet, S., Sobilo, J., Hérault, O., Lecomte, T., Vandier, C., Raoul, W., & Guéguinou, M. (2024). MICU2 up-regulation enhances tumor aggressiveness and metabolic reprogramming during colorectal cancer development. PLOS Biology. https://doi.org/10.1371/journal.pbio.3002854
Vancouver
Robert A, Crottès D, Bourgeais J, Gueguen N, Chevrollier A, Dumas JF, et al. MICU2 up-regulation enhances tumor aggressiveness and metabolic reprogramming during colorectal cancer development. PLOS Biology. 2024. doi:10.1371/journal.pbio.3002854
BibTeX
@article{Robert2024,
author = {Robert, Alison and Crottès, David and Bourgeais, Jérôme and Gueguen, Naig and Chevrollier, Arnaud and Dumas, Jean-François and Servais, Stéphane and Domingo, Isabelle and Chadet, Stéphanie and Sobilo, Julien and Hérault, Olivier and Lecomte, Thierry and Vandier, Christophe and Raoul, William and Guéguinou, Maxime},
title = {MICU2 up-regulation enhances tumor aggressiveness and metabolic reprogramming during colorectal cancer development},
journal = {PLOS Biology},
year = {2024},
doi = {10.1371/journal.pbio.3002854}
}
EUVIMED